查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968674

生物製藥生產設備及耗材市場分析及預測（至2035年）：類型、產品、服務、技術、組件、應用、材質類型、製程、最終用戶及功能

Biopharmaceutical Processing Equipment And Consumables Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Process, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 474 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生物製藥生產設備及耗材市場預計將從2024年的438億美元成長至2034年的1,076億美元，複合年成長率約為9.4%。該市場涵蓋藥物研發和生產所需的關鍵設備和材料，例如生物反應器、過濾系統和層析法設備。該產業為生物製藥、疫苗和生物相似藥的生產提供支持。對個人化醫療和生物製藥日益成長的需求正在推動市場成長，而一次性技術和流程自動化的進步則提高了效率和擴充性。

生物製藥生產設備及耗材市場正經歷強勁成長，主要得益於生物製藥和生物相似藥生產技術的進步。設備領域在該市場中佔據主導地位，其中生物反應器和過濾系統是高效生物製程的關鍵設備。層析法系統在提升純化製程方面也扮演重要角色。耗材領域緊隨其後，尤其是過濾耗材和層析法樹脂，它們在確保產品純度和品質方面發揮著至關重要的作用。一次性技術因其成本效益和降低污染風險而日益普及，對成熟和新興的生物製藥企業都極具吸引力。下游設備和耗材的需求不斷成長，反映出該產業對最佳化純化和分離製程的重視。自動化和流程分析領域的創新透過提高營運效率和產品一致性，進一步推動了市場成長。對個人化醫療以及細胞和基因療法的日益關注預計將推動未來的市場擴張，為這個充滿活力的市場中的相關人員帶來盈利的機會。

市場區隔
類型 一次性使用，可重複使用
產品 過濾系統、層析法系統、生物反應器、混合器、離心機、袋裝和容器、管路、連接器、閥門
服務 安裝、維護、驗證、資格確認、培訓
科技 上游工程、下游製程、細胞培養、發酵、純化
成分 感測器、控制器、馬達、泵浦
應用 單株抗體、疫苗、重組蛋白、細胞療法、基因療法
材質 不鏽鋼、塑膠、玻璃
過程 批量處理，連續處理
最終用戶 生物製藥公司、契約製造組織、學術研究機構
功能 自動化、手動

市場概況：

生物製藥加工設備及耗材市場的特徵是市佔率分佈動態變化、定價策略靈活、創新產品層出不窮。主要企業不斷利用最尖端科技拓展產品系列，以滿足生物製藥產業不斷變化的需求。這種策略擴張的驅動力在於提高藥物研發和生產流程的效率和生產力。一次性系統因其成本效益和操作柔軟性而備受青睞，市場需求激增。北美和歐洲引領市場，而亞太地區的新興經濟體正憑藉著不斷成長的投資迅速追趕。競爭基準分析顯示，市場結構高度分散，多家主要企業競相爭取主導。監管影響，尤其是在北美和歐洲，透過制定嚴格的品質和安全標準，在塑造市場動態發揮關鍵作用。企業越來越重視合規性，以獲得競爭優勢。技術進步使自動化數位化成為企業營運的核心，這也對市場產生影響。這些因素，加上研發投入的不斷增加，共同推動了市場成長。儘管營運成本高、監管環境複雜等挑戰依然存在，但在生物製程技術創新的支持下，市場前景依然樂觀。

主要趨勢和促進因素：

生物製藥生產設備和耗材市場正經歷強勁成長，這主要得益於技術創新和對生物製藥日益成長的需求。關鍵趨勢包括一次性技術的應用，這些技術在生產過程中具有成本效益和柔軟性。由於它們能夠降低污染風險並提高生產效率，因此變得至關重要。慢性病的增加是推動市場成長的關鍵因素，這需要先進的生物製藥解決方案。這種需求促使企業不斷創新產品並拓展產品線。此外，監管部門對生物製藥和生物相似藥的支持也促進了市場擴張，簡化的核准流程縮短了產品上市時間。生物製程的客製化和擴充性正成為關鍵趨勢。企業正在投資建造可根據特定生產需求量身定做的模組化設施，從而確保適應性和效率。此外，自動化和數據分析等數位技術的整合正在革新製程最佳化，並實現即時監控。這些進步為市場參與者創造了盈利機會，使其能夠提高產能並滿足不斷成長的全球需求。

限制與挑戰：

生物製藥生產設備和耗材市場面臨許多重大限制和挑戰。其中一個主要挑戰是先進設備的高成本，這可能會阻礙中小企業進入市場。這種財務壁壘限制了創新和競爭。此外，嚴格的監管要求導致產品核可延遲和營運成本增加。遵守這些法規需要投入大量的時間和資源。另外，生物製藥製程的複雜性需要熟練的專業人員，但合格人員卻短缺。這種技能缺口會阻礙高效率營運和創新。供應鏈中斷，尤其是受全球事件影響的供應鏈中斷，也影響了原料和設備的及時採購。最後，技術的快速發展可能導致現有設備過時，需要不斷投資進行設備升級，這可能會對企業造成沉重的財務負擔。這些因素共同限制了市場成長，並構成了進入障礙。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 一次性
    • 可重複使用類型
  • 市場規模及預測：依產品分類
    • 過濾系統
    • 層析法系統
    • 生物反應器
    • 混合器
    • 離心機
    • 袋子和容器
    • 管子
    • 連接器
    • 閥門
  • 市場規模及預測：依服務分類
    • 安裝
    • 維護管理
    • 驗證
    • 資格
    • 訓練
  • 市場規模及預測：依技術分類
    • 上游工程
    • 下游工藝
    • 細胞培養
    • 發酵
    • 純化
  • 市場規模及預測：依組件分類
    • 感應器
    • 控制器
    • 引擎
    • 泵浦
  • 市場規模及預測：依應用領域分類
    • 單株抗體
    • 疫苗
    • 重組蛋白
    • 細胞療法
    • 基因治療
  • 市場規模及預測：依材料類型分類
    • 不銹鋼
    • 塑膠
    • 玻璃
  • 市場規模及預測：依製程分類
    • 批量處理
    • 連續加工
  • 市場規模及預測：依最終用戶分類
    • 生物製藥公司
    • 契約製造組織
    • 學術研究機構
  • 市場規模及預測：依功能分類
    • 自動化
    • 手動的

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Sartorius Stedim Biotech
  • Eppendorf AG
  • GEA Group
  • Pall Corporation
  • Merck Millipore
  • Thermo Fisher Scientific
  • Watson-Marlow Fluid Technology Group
  • Repligen Corporation
  • Avantor Inc
  • Corning Incorporated
  • Sani-Tech West
  • Sartorius AG
  • 3M Company
  • Danaher Corporation
  • Applikon Biotechnology
  • Meissner Filtration Products
  • Parker Hannifin Corporation
  • Saint-Gobain Life Sciences
  • Cole-Parmer
  • Getinge AB

第9章：關於我們

簡介目錄
Product Code: GIS33054

Biopharmaceutical Processing Equipment And Consumables Market is anticipated to expand from $43.8 billion in 2024 to $107.6 billion by 2034, growing at a CAGR of approximately 9.4%. The Biopharmaceutical Processing Equipment and Consumables Market encompasses tools and materials essential for drug development and production, including bioreactors, filtration systems, and chromatography tools. This sector supports the manufacture of biologics, vaccines, and biosimilars. Increasing demand for personalized medicine and biologics is propelling growth, with advancements in single-use technologies and process automation enhancing efficiency and scalability.

The Biopharmaceutical Processing Equipment and Consumables Market is experiencing robust growth, fueled by advancements in biologics and biosimilars production. Within this market, the equipment segment is leading, with bioreactors and filtration systems being pivotal for efficient bioprocessing. Chromatography systems also play a significant role, enhancing purification processes. The consumables segment, particularly filtration consumables and chromatography resins, follows closely, driven by their critical function in ensuring product purity and quality. Single-use technologies are gaining momentum due to their cost-effectiveness and reduced contamination risk, appealing to both established and emerging biopharmaceutical manufacturers. Downstream processing equipment and consumables are witnessing increased demand, reflecting the industry's focus on optimizing purification and separation processes. Innovations in automation and process analytics are further propelling market growth, as they enhance operational efficiency and product consistency. The emphasis on personalized medicine and cell and gene therapies is expected to drive future expansion, offering lucrative opportunities for stakeholders in this dynamic market.

Market Segmentation
TypeSingle-Use, Reusable
ProductFiltration Systems, Chromatography Systems, Bioreactors, Mixers, Centrifuges, Bags and Containers, Tubes, Connectors, Valves
ServicesInstallation, Maintenance, Validation, Qualification, Training
TechnologyUpstream Processing, Downstream Processing, Cell Culture, Fermentation, Purification
ComponentSensors, Controllers, Motors, Pumps
ApplicationMonoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapy, Gene Therapy
Material TypeStainless Steel, Plastic, Glass
ProcessBatch Processing, Continuous Processing
End UserBiopharmaceutical Companies, Contract Manufacturing Organizations, Academic and Research Institutes
FunctionalityAutomated, Manual

Market Snapshot:

The biopharmaceutical processing equipment and consumables market is characterized by a dynamic landscape of market share distribution, strategic pricing, and innovative product launches. Leading companies are continuously expanding their portfolios with cutting-edge technologies to cater to the evolving demands of the biopharmaceutical sector. This strategic expansion is driven by the need for enhanced efficiency and productivity in drug development and manufacturing processes. The market is witnessing a surge in demand for single-use systems, driven by their cost-effectiveness and operational flexibility. Geographically, North America and Europe are at the forefront of this market, while emerging economies in Asia-Pacific are rapidly catching up due to increased investments. Competitive benchmarking reveals a highly fragmented market with several key players vying for dominance. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, setting stringent standards for quality and safety. Companies are increasingly focusing on compliance to gain a competitive edge. The market is also influenced by technological advancements, with automation and digitalization becoming central to operations. These factors, coupled with increasing R&D investments, are driving growth. Challenges such as high operational costs and complex regulatory landscapes persist, yet the market's future outlook remains optimistic, bolstered by innovations in bioprocessing technologies.

Geographical Overview:

The biopharmaceutical processing equipment and consumables market is witnessing robust expansion across diverse regions. North America leads, propelled by its advanced healthcare infrastructure and substantial investments in biopharmaceutical research and development. The region's focus on innovation and technological advancements enhances its market dominance. Europe follows, with strong regulatory frameworks and a thriving pharmaceutical industry driving growth. The region's emphasis on quality and compliance bolsters its market position. In Asia Pacific, the market is burgeoning, supported by rapid industrialization and increasing healthcare demands. Countries like China and India are emerging as major growth pockets, owing to their large patient populations and expanding pharmaceutical sectors. Latin America and the Middle East & Africa are also gaining traction. In Latin America, government initiatives to bolster healthcare infrastructure are contributing to market growth. Meanwhile, the Middle East & Africa are recognizing the potential of biopharmaceutical processing equipment in advancing healthcare outcomes and fostering economic development.

Key Trends and Drivers:

The biopharmaceutical processing equipment and consumables market is experiencing robust growth fueled by technological advancements and increasing demand for biologics. Key trends include the adoption of single-use technologies, which offer cost-effectiveness and flexibility in manufacturing processes. These technologies are becoming vital as they reduce contamination risks and enhance production efficiency. The growing prevalence of chronic diseases is a significant driver, necessitating advanced biopharmaceutical solutions. This demand is pushing companies to innovate and expand their product pipelines. Furthermore, regulatory support for biologics and biosimilars is encouraging market expansion, as streamlined approval processes facilitate quicker time-to-market. Customization and scalability in bioprocessing are emerging as crucial trends. Companies are investing in modular equipment that can be tailored to specific production needs, ensuring adaptability and efficiency. Additionally, the integration of digital technologies like automation and data analytics is revolutionizing process optimization, providing real-time monitoring and control. These advancements are creating lucrative opportunities for market players to enhance production capabilities and meet the rising global demand.

Restraints and Challenges:

The biopharmaceutical processing equipment and consumables market faces several significant restraints and challenges. One primary challenge is the high cost of advanced equipment, which can deter small and medium-sized enterprises from entering the market. This financial barrier limits innovation and competition. Additionally, stringent regulatory requirements can delay product approvals and increase operational costs. Compliance with these regulations demands significant investment in time and resources. Furthermore, the complexity of biopharmaceutical processes necessitates skilled personnel, yet there is a shortage of qualified professionals. This skills gap can hinder efficient operations and innovation. Supply chain disruptions, exacerbated by global events, pose another challenge, affecting the timely availability of raw materials and equipment. Lastly, the rapid pace of technological advancements can render existing equipment obsolete, necessitating continuous investment in upgrades, which can be financially burdensome for companies. These factors collectively constrain market growth and accessibility.

Key Players:

Sartorius Stedim Biotech, Eppendorf AG, GEA Group, Pall Corporation, Merck Millipore, Thermo Fisher Scientific, Watson-Marlow Fluid Technology Group, Repligen Corporation, Avantor Inc, Corning Incorporated, Sani-Tech West, Sartorius AG, 3M Company, Danaher Corporation, Applikon Biotechnology, Meissner Filtration Products, Parker Hannifin Corporation, Saint-Gobain Life Sciences, Cole-Parmer, Getinge AB

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by End User
  • 2.10 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Single-Use
    • 4.1.2 Reusable
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Filtration Systems
    • 4.2.2 Chromatography Systems
    • 4.2.3 Bioreactors
    • 4.2.4 Mixers
    • 4.2.5 Centrifuges
    • 4.2.6 Bags and Containers
    • 4.2.7 Tubes
    • 4.2.8 Connectors
    • 4.2.9 Valves
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Installation
    • 4.3.2 Maintenance
    • 4.3.3 Validation
    • 4.3.4 Qualification
    • 4.3.5 Training
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Upstream Processing
    • 4.4.2 Downstream Processing
    • 4.4.3 Cell Culture
    • 4.4.4 Fermentation
    • 4.4.5 Purification
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Controllers
    • 4.5.3 Motors
    • 4.5.4 Pumps
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Monoclonal Antibodies
    • 4.6.2 Vaccines
    • 4.6.3 Recombinant Proteins
    • 4.6.4 Cell Therapy
    • 4.6.5 Gene Therapy
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Stainless Steel
    • 4.7.2 Plastic
    • 4.7.3 Glass
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Batch Processing
    • 4.8.2 Continuous Processing
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Biopharmaceutical Companies
    • 4.9.2 Contract Manufacturing Organizations
    • 4.9.3 Academic and Research Institutes
  • 4.10 Market Size & Forecast by Functionality (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Material Type
      • 5.2.1.8 Process
      • 5.2.1.9 End User
      • 5.2.1.10 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Material Type
      • 5.2.2.8 Process
      • 5.2.2.9 End User
      • 5.2.2.10 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Material Type
      • 5.2.3.8 Process
      • 5.2.3.9 End User
      • 5.2.3.10 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Material Type
      • 5.3.1.8 Process
      • 5.3.1.9 End User
      • 5.3.1.10 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Material Type
      • 5.3.2.8 Process
      • 5.3.2.9 End User
      • 5.3.2.10 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Material Type
      • 5.3.3.8 Process
      • 5.3.3.9 End User
      • 5.3.3.10 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Material Type
      • 5.4.1.8 Process
      • 5.4.1.9 End User
      • 5.4.1.10 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Material Type
      • 5.4.2.8 Process
      • 5.4.2.9 End User
      • 5.4.2.10 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Material Type
      • 5.4.3.8 Process
      • 5.4.3.9 End User
      • 5.4.3.10 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Material Type
      • 5.4.4.8 Process
      • 5.4.4.9 End User
      • 5.4.4.10 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Material Type
      • 5.4.5.8 Process
      • 5.4.5.9 End User
      • 5.4.5.10 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Material Type
      • 5.4.6.8 Process
      • 5.4.6.9 End User
      • 5.4.6.10 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Material Type
      • 5.4.7.8 Process
      • 5.4.7.9 End User
      • 5.4.7.10 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Material Type
      • 5.5.1.8 Process
      • 5.5.1.9 End User
      • 5.5.1.10 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Material Type
      • 5.5.2.8 Process
      • 5.5.2.9 End User
      • 5.5.2.10 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Material Type
      • 5.5.3.8 Process
      • 5.5.3.9 End User
      • 5.5.3.10 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Material Type
      • 5.5.4.8 Process
      • 5.5.4.9 End User
      • 5.5.4.10 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Material Type
      • 5.5.5.8 Process
      • 5.5.5.9 End User
      • 5.5.5.10 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Material Type
      • 5.5.6.8 Process
      • 5.5.6.9 End User
      • 5.5.6.10 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Material Type
      • 5.6.1.8 Process
      • 5.6.1.9 End User
      • 5.6.1.10 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Material Type
      • 5.6.2.8 Process
      • 5.6.2.9 End User
      • 5.6.2.10 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Material Type
      • 5.6.3.8 Process
      • 5.6.3.9 End User
      • 5.6.3.10 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Material Type
      • 5.6.4.8 Process
      • 5.6.4.9 End User
      • 5.6.4.10 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Material Type
      • 5.6.5.8 Process
      • 5.6.5.9 End User
      • 5.6.5.10 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Sartorius Stedim Biotech
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Eppendorf AG
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 GEA Group
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Pall Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Merck Millipore
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Thermo Fisher Scientific
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Watson-Marlow Fluid Technology Group
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Repligen Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Avantor Inc
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Corning Incorporated
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Sani-Tech West
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Sartorius AG
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 3M Company
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Danaher Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Applikon Biotechnology
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Meissner Filtration Products
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Parker Hannifin Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Saint-Gobain Life Sciences
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Cole-Parmer
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Getinge AB
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us